American Association for Cancer Research

2011 Minority-Serving Institution Faculty Scholars in Cancer Research

 Antonio Baines

Antonio T. Baines, Ph.D.
North Carolina Central University, Durham, NC

“I plan to continue building my research program in pancreatic cancers by collaborating with researchers from academia and industry. Also, I want to encourage students from diverse backgrounds to pursue careers in cancer research.”

Abstract #256 Downregulation of Pim-3 kinase inhibits cell growth and chemosensitizes pancreatic cancer cells to gemcitabine.
Poster Session: Sunday, April 3, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Hirendra Banerjee

Hirendra N. Banerjee, M.D., Ph.D.
Elizabeth City State University, Elizabeth City, NC

"My goals are to continue teaching, studying the effect of novel anticancer drugs on different cancer cell lines, and preparing future minority researchers in field of cancer."

Abstract #4939 Analysis of micro RNA status in brain cancer glioblastoma multiforme
Poster Session: Wednesday, April 6, 2011, 8:00 am - 12:00 pm, Orange County Convention Center, Exhibit Hall A4C 

Brandi Brandon Knight

Brandi Brandon Knight, Ph.D.
Morehouse School of Medicine, Atlanta, GA

"My long-range career objectives are: to develop a post-baccalaureate program that will bridge undergraduate education to graduate training programs; to restructure the medical enrichment program at Morehouse School of Medicine; and to establish a successful mentoring program for students in all degree programs."

 Iona Cheng

Iona C. Cheng, Ph.D.
University of Hawaii, Honolulu, HI

“My long-term objectives are to identify the genetic, environmental, and social factors that contribute to racial/ethnic differences in cancer risk, such as the factors that drive the greater burden of prostate cancer among African Americans.”

Abstract #3760 Associations of risk variants for 20 different malignancies with colorectal cancer in a multiethnic population.
Poster Session: Tuesday, April 5, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Room W415 B/C (Valencia Ballroom)

Abstract #2755 Association of established risk variants for obesity and type-2 diabetes with dietary intake in the Multiethnic Cohort Study.
Poster Session: Monday, April 4, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

Abstract #884 Pleiotropic effects on lung cancer of genetic susceptibility variants identified for other malignancies: The multiethnic cohort.
Poster Session: Sunday, April 3, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

Abstract #4732 Cis-expression QTL analysis of established risk variants for colorectal cancer.
Poster Session: Tuesday, April 5, 2011, 3:00 pm - 5:00 pm, Orange County Convention Center, Room W414 A/B

Abstract# LB-348 Integrated analysis of microRNA and mRNA expression in microsatellite-stable colon cancer using next-generation sequencing and cDNA microarrays. Poster Session: April 05, 1:00 pm - 5:00 pm, Exhibit Hall A4-C, Poster Section 37

 Vivan Colon-Lopez

Vivian Colon-Lopez, Ph.D., M.P.H.
University of Puerto Rico Medical Science Campus, San Juan PR

“My goal is to become an independent investigator in the area of cancer epidemiology, with a particular focus in the prevention and control of HPV-related cancers among minority populations.”

Abstract #1929 Incidence and mortality rates of penile cancer among men in Puerto Rico and the United States.
Poster Session: Monday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

 Charles desBordes

Charles desBordes, Ph.D.
City University of New York, Brooklyn, NY

“Research on the relationship of nutrition to cancer risk is the next logical progression of my current research thrust, and translating my research experiences into direct and obvious benefit to my students and community remains my ultimate goal.”

Abstract #4069 2-deoxyglucose and compound C reversed acidification but enhanced growth inhibition in colon cancer cells treated with metformin and phenformin.
Poster Session: Tuesday, April 5, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Ibtissim Echchgadda

Ibtissam Echchgadda, Ph.D.
UT Health Science Center, San Antonio, TX

“My long-range career objective is to launch an independent research career in prostate cancer biology. My goal is to pursue research in unexplored areas of prostate cancer therapeutics.”

Abstract #361 Calcitriol-dependent induction of the human sulfotransferase SULT2B1 in the prostate: Implication in the growth inhibition of prostate cancer.
Poster Session: Sunday, April 3, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Kristina Flores

Kristina G. Flores, Ph.D.
University of New Mexico, Albuquerque, NM

“My long-term goal is to build a research program that will incorporate molecular epidemiology and epigenetics to identify more effective strategies for cancer detection and treatment, in particular lung cancer and melanoma. I also hope to build upon my collaborations with diverse populations in New Mexico to identify cancer prevention strategies that are relevant to their needs.”

Abstract #891 The association of single nucleotide polymorphisms in folate metabolism genes with hypermethylation patterns in smokers at high risk for lung cancer
Poster Session: Sunday, April 3, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Hernan Flores-Rozas

Hernan Flores-Rozas, Ph.D.
Florida A&M University, Tallahassee, FL

“My long-term career goals are to continue in academia and develop a competitive extramurally funded program in anti-cancer drug discovery. Of particular interest is to identify new targets for cancer therapy and develop therapeutic protocols. I will devote significant effort to investigate the response of minority populations to such therapies, since a number of cancers, such as breast cancer and prostate cancer, affect minority groups more severely.”

Abstract #4475 Inhibition of amino acid biosynthetic pathways lead to increase sensitivity to anthracyclines in Saccharomyces cerevisiae.
Poster Session: Tuesday, April 5, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Shanchun Guo

Shanchun Guo, Ph.D.
Morehouse School of Medicine, Atlanta, GA

“My career goal is to become a leading investigator, to make substantial contributions to better diagnosis and development of mechanism-driven targeted therapies for breast cancer.”

Abstract #825 Leptin signaling disruption prevents DMBA-induced mammary tumors in lean and diet-induced-obesity (DIO) mice.
Poster Session: Monday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #1009 Leptin induces Src/Gbr2/Gab2/STAT3 activation and Rac-1 crosstalk to regulate VEGF/VEGFR2 in breast cancer.
Poster Session: Sunday, April 3, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

Abstract #4086 Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin regulation of VEGF/VEGFR-2 in breast cancer.
Poster Session: Tuesday, April 5, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Ali Ishaque

Ali B. Ishaque, Ph.D.
University of Maryland Eastern Shore, Princess Anne, MD

"My goals are to develop an independent research program in cancer at UMES campus and finally attain full professorship at the department of natural sciences."

 Stan Ivey

Stan Ivey, Ph.D.
Delaware State University, Dover, DE

“My long-range career objectives are to continue to teach and research at DSU. I would like to continue to receive research grants from the NIH to achieve the above cancer research goals to show that indeed changing glycans can be used to stage cancer cells.”

Abstract #5268 CXCR4 and P-glycoprotein N-glycan patterning in developing cancer cells.
Poster Session: Tuesday, April 6, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

 Khosrow Kashfi

Khosrow Kashfi, Ph.D., F.R.S.C.
City University of New York Medical School, New York, NY

“I love teaching, so I hope to continue in that capacity for years to come. In terms of research, I hope to develop some of my ideas further, expand our library of small molecules that have chemopreventive/chemotherapeutic potential and hopefully get one or two agents into clinical trials.”

Abstract #3128 Hydrogen sulfide-releasing NSAIDs inhibit the growth of cultured human cancer cells: A general property and evidence of a tissue type-independent effect.
Poster Session: Tuesday, April 5, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #1349 Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
Poster Session: Monday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #807 Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo.
Poster Session: Sunday, April 3, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

Abstract #4608 Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression.
Poster Session: Tuesday, April 5, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

Abstract #1353  Hydrogen sulfide-releasing naproxen inhibits HT-29 human colon cancer cell growth: Modulation of NF-κB.
Poster Session: Monday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #5560 All three positional isomers of acetyl salicylic acids are equally potent in inhibiting colon cancer cell growth: Differences in mode of COX inhibition.
Poster Session: Wednesday, April 6, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

 Ward Kirlin

Ward G. Kirlin, Ph.D.
Morehouse School of Medicine, Atlanta, GA

“Maintaining an active research program is a top priority in my career objectives. My involvement in the area of chemical carcinogenesis and cancer prevention is both stimulating and provides a solid platform for training minority scientists.”

Abstract #1850 Benzyl isothiocyanate causes proteasome-mediated degradation of aryl hydrocarbon receptor in Hepa1c1c7 cells.
Poster Session: Sunday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

 Addanki Kumar

Addanki Pratap Kumar, Ph.D.
UT Health Science Center, San Antonio, TX

“My long-term research objective is to understand molecular events associated with cancer progression using in vitro and in vivo pre-clinical animal models with the goal of translation to the bedside. In addition another objective of my research program is to understand the genetic and epigenetic differences that could contribute to the development and progression of cancer in minorities.”

Abstract #3544 Jak/Stat signaling: A potential target for pancreatic cancer management.
Poster Session: Tuesday, April 5, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #4951 2-Methoxyestradiol (2-ME2) induces microRNA alterations in prostate cancer cells: Role for miRs in 2-ME2-induced biological effects.
Poster Session: Wednesday, April 6, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #851 Interactions among transcription factors as a potential mechanism for inhibiting castrate-resistant prostate cancer (CRPCa) in transgenic adenocarcinoma of mouse prostate (TRAMP) through regulation of FLIP.
Poster Session: Sunday, April 3, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Dong Liang

Dong Liang, Ph.D.
Texas Southern University, Houston, TX

“My long-term research goals are towards fast-track discovery of personalized cancer treatment using pharmacogenetics, pharmacology, and novel drug delivery technologies.”

Abstract #4669 Genetic variations in telomere pathway genes and ovarian cancer risk, survival and treatment response.
Poster Session: Tuesday, April 5, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Amosy M'Koma

Amosy E. M’Koma, M.D., Ph.D.
Meharry Medical College, Nashville, TN

“My research is to clarify and try to improve diagnostic accuracy for easy, affordable noninvasive and fast screening in inflammatory bowel disease (IBD) associated colorectal cancer (CRC) through molecular differences between ulcerative colitis (UC) and Crohn's colitis (CC). My approach is to perform thorough proteomic analyses of normal and pathologic human colonic tissue and identify proteins that are differentially unique and characteristic of two different colonic diseases with similar and overlapping clinical features, but requires significantly different treatments. The identification of proteins that are characteristic of specific colitides will significantly enhance our hypotheses and ideas related to pathological events associates with IBD-CRC. We anticipate that this approach will eventually provide proteins of interest that can delineate the inflammatory colitides through endoscopic biopsy samples and hopefully create a serum biomarker assay for the same peptide. Finally, a better understanding of the pathophysiologic mechanisms may aid in prevention and create new therapeutic options for maintenance of remission in IBD and, therefore, CRC prevention."

Abstract# LB-428 Upregulation of serum amyloid A1 (SAA 1) gene is associated with ulcerative colitis-related colon cancer.  Poster Session: April 06, 8:00 am - 12:00 noon, Exhibit Hall A4-C, Poster Section 37.

Abstract# LB-450 Gene expression of colonic submucosa differs between the inflammatory colitides. A possible reason for differences in IBD-associated CRC incidences? Poster Session: April 06, 8:00 am - 12:00 noon, Exhibit Hall A4-C, Poster Section 38.

Abstract# LB-463 Proteomic patterns of colonic submucosa delineates the inflammatory colitides. This could aid understand IBD-related colorectal malignancy. Poster Session: April 06, 8:00 am - 12:00 noon, Exhibit Hall A4-C, Poster Section 38.

 Patrick Martin

Patrick M. Martin, Ph.D.
North Carolina A&T State University, Greensboro, NC

“My long-term career goal is to establish myself as a competitive cancer biology researcher, educator, and mentor of minority students interested in cancer biology. Eventually, I would like to become an administrator at an emerging institution so that I can advocate for more scientific research, especially cancer-related research.”

Abstract #2933 Inhibition of MAPK signaling prevents Fra-1-mediated CD44 expression in human brain tumor cells.
Poster Session: Monday, April 5, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

 Magaly Martinez-Ferrer

Magaly Martinez-Ferrer, Ph.D.
University of Puerto Rico Comprehensive Cancer Center, San Juan, PR

“One of my goals is to become an independent investigator in the area of inflammation and urological cancer at an academic institution. I plan to have a fully funded laboratory with more students and personnel working in different projects. I also enjoy teaching as it is an important to complement to my research.”

Abstract #391 Inflammatory mediators of prostate cancer metastasis
Poster Session: Sunday, April 3, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

Abstract #1929 Incidence and mortality rates of penile cancer among men in Puerto Rico and the United States.
Poster Session: Sunday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

 Ana Ortiz Martinez

Ana P. Ortiz Martinez, M.P.H., Ph.D.
University of Puerto Rico Comprehensive Cancer Center, San Juan, PR

“My career goal is to transition into an independent investigator and become a leader in the field of cancer epidemiology and health disparities, with a focus in the prevention and control of female cancers, particularly cervical, breast and endometrial cancers.”

Abstract #1929 Incidence and mortality rates of penile cancer among men in Puerto Rico and the United States.
Poster Session: Sunday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

 Sederick Rice

Sederick C. Rice, Ph.D.
University of Arkansas at Pine Bluff, Pine Bluff, AR

"My long-range career objectives are to become a hypothesis-driven, externally funded cancer researcher, and study the development and progression of primary tumors into metastatic cancers using translational bioinformatics."

 Checo Rorie

Checo J. Rorie, Ph.D.
North Carolina A&T State University, Greensboro, NC

"My ultimate long-term goals, within the next 5-7 years, are to secure an NIH R01 grant and to establish myself as a successful independent researcher. I will earn tenure within the time-frame and continue to write research grants and publish."

Abstract #2141 The differential apoptotic responses of normal breast cells versus luminal and triple negative breast cancer cells to chemotherapeutic agents.
Poster Session: Monday, April 4, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Pothana Saikumar

Pothana Saikumar, Ph.D.
UT Health Science Center, San Antonio, TX

“My long-term goals are to develop a strong cancer research program that emphasizes translational aspects of science through collaborations with clinician scientists and to train future leaders.”

Abstract #5179 TMEPAI, a negative regulator of Smad signaling switches tumor suppressive TGF- β to a tumor promoter in breast tumorigenesis.
Poster Session: Wednesday, April 6, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

 Amos Sakwe

Amos M. Sakwe, Ph.D.
Meharry Medical College, Nashville, TN

“My ultimate career goal is to establish a sustainable basic cancer research laboratory to study the molecular basis of cancer metastasis with emphasis on the role of the often overlooked cancer-induced high systemic Ca2+ or hypercalcemia of mailgnancy.”

Abstract #2119 Role of annexin A6 in anchorage-independent growth of invasive breast cancer cells.
Poster Session: Monday, April 4, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Temesgen Samuel

Temesgen Samuel, D.V.M., Ph.D.
UT Health Science Center, San Antonio, TX

“My long-term goal is to be an independent researcher in investigations of how dietary and other natural compounds modulate cell signaling pathways in cancer cells, and how the compounds affect pathways targeted by therapeutic agent; and molecular signatures of aggressive colon cancer among African Americans.”

Abstract #2005 Modulation of tumor suppressor gene DNA-methylation by quercetin and dietary indoles.
Poster Session: Monday, April 4, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Shengmin Sang

Shengmin Sang, Ph.D.
North Carolina A&T State University Center for Excellence in Post-Harvest Technologies, Kannapolis, NC

“My long-term research goals are to better understand the cancer preventive effects of functional foods and their bioactive components and develop dietary supplements or drug candidates to prevent/treat human cancer.”

Abstract #4617 Bioactive phytochemicals in wheat bran for colon cancer prevention.
Poster Session: Tuesday, April 5, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Pedro Santiago

Pedro G. Santiago-Cardona, Ph.D.
Ponce School of Medicine, Ponce, PR

“My long-range goals are to establish a solid track record of publications demonstrating a significant contribution to the cancer biology field; contribute to the training and education of future generations of cancer biologists, especially underrepresented minorities; and eventually receive a promotion to Full Professor rank."

Abstract #4025 The retinoblastoma protein regulates cell adhesion: Implications for lung cancer progression.
Poster Session: Tuesday, April 5, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Anjana Saxena

Anjana D. Saxena, Ph.D.
City University of New York Brooklyn College, New York, NY

"My long-term goal is to define the role of nucleolar stress-responsive proteins in tumorigenesis and identify small-molecule inhibitors as potential cancer-therapeutics."

Abstract #2967 Nucleolin phosphorylation by CK2 modulates its role in cell cycle checkpoint activation.
Poster Session: Tuesday, April 5, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C                                

 Shailesh Singh

Shailesh Singh, Ph.D.
Morehouse School of Medicine, Atlanta, GA

“My long-term career objectives and research goals are to better define the cancer progression and develop treatment and prevention modalities directed to host.”

Abstract #5257 Expression and functional role of CXCR5 and CXCL13 in non-small cell lung carcinoma (NSCLC)
Poster Session: Wednesday, April 6, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4-C

Abstract #940 Expression and functional role of CCR9 in lung cancer.
Poster Session: Wednesday, April 6, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4-C

 Chung Seog Song

Chung Seog Song, Ph.D.
UT Health Science Center, San Antonio, TX

“My long-range career goals are: 1) Prepare and submit a research grant with a translational focus; 2) Publish high-profile research papers in the area of prostate cancer; 3) career advancement (promotion to Associate Professorship).”

Abstract #361 Calcitriol-dependent induction of the human sulfotransferase SULT2B1 in the prostate: Implication in the growth inhibition of prostate cancer.
Poster Session: Sunday, April 3, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Maribel Tirado-Gomez

Maribel Tirado-Gómez, M.D.
University of Puerto Rico Comprehensive Cancer Center, San Juan, PR

“My long-term career goal is to become an independent researcher in the area of hematologic malignancies.”

Abstract #2766 DNA methylation status of MLH1, p16 and SOCS1 in Puerto Rican patients with acute myeloid leukemia.
Poster Session: Monday, April 4, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Ratna Vadlamudi

Ratna K. Vadlamudi, Ph.D.
UT Health Science Center, San Antonio, TX

"My goals are to establish a strong research program for studying the role of coregulators in cancer progression; to recruit and train postdoctoral/graduate students in the area of hormonal cancers; and to establish synergistic research collaborations in the area of coregulators and cancer progression."

Abstract #1464 Significance and therapeutic potential of PELP1 axis in ER-negative breast cancer.
Poster Session: Monday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #73 PELP1 is a novel reader of chromatin modifications: Implications in cancer progression.
Poster Session: Sunday, April 3, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

Abstract #1733 Therapeutic significance of ERα—PELP1 axis in blocking endocrine therapy resistance.
Poster Session: Monday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #2297 ERβ agonists reduce letrozole resistant breast cancer cell growth and diminish aromatase expression and activity.
Poster Session: Monday, April 4, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Cynthia van Golen

Cynthia M. van Golen, Ph.D.
Delaware State University, Dover, DE

“My long-range goals are to expand my research program, increase the quality and quantity of my work to RO1 level caliber, and make significant contributions to my department, institution, and the broader scientific community. I will also continue to expand my research into understanding the reasons behind racial disparities in cancer, particularly prostate and breast cancer.”

Abstract #2085 Reactive oxygen species promote signaling in neuroblastoma cells.
Poster Session: Monday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #2924  IGF-IR inibition induces MAPK signaling in prostate carcinoma cells.
Poster Session: Tuesday, April 5, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #2425 Mechanisms of neuroblastoma metastasis to bone.
Poster Session: Monday, April 4, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

Abstract #1435 Analyzing the role of CXCR and IGF-IR in modulating actin dynamics in neuroblastoma cells.
Poster Session: Monday, April 4, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Pablo Vivas-Mejia

Pablo E. Vivas-Mejía, Ph.D.
University of Puerto Rico Comprehensive Cancer Center, San Juan, PR

“My ultimate goal is to understand the cancer etiology and eliminate cancer disparities of ethnic minority populations.”

Abstract #1706 Microarray analysis of gene expression reveals that several mTOR related genes are upregulated in cisplatin resistant ovarian cancer cells.
Poster Session: Monday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #937 Molecular dynamics of SrcS17 activation in chronic stress-induced tumor growth.
Poster Session: Sunday, April 3, 2011, 3:15 pm - 5:15 pm, Orange County Convention Center, Room W315

Abstract #1735 Silencing survivin splice variant 2B leads to antitumor activity in taxane-resistant ovarian cancer.
Poster Session: Monday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #1618 Erythropoietin meets a new receptor
Poster Session: Monday, April 4, 2011, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #4457 In Search of a novel EPO receptor: The clinical significance of the Eph connection
Poster Session: Tuesday, April 5, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Clement Yedjou

Clement G. Yedjou, Ph.D.
Jackson State University, Jackson, MS

“My long-range career objectives and research goals are to become a top-ranked junior faculty at Jackson State University, and to establish myself as an internationally recognized biomedical researcher in the field of pharmacology, toxicology, and therapeutics.”

Abstract #1322 Molecular mechanisms of high glucose-induced toxicity in human breast adenocarcinoma (Mcf-7) cells.
Poster Session: Monday, April 4, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

Abstract #4209 Genotoxic effects of arsenic trioxide-induced oxidative stress in human hepatocellular carcinoma (HepG2) cells.
Poster Session: Tuesday, April 5, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

 Beatriz Zayas

Beatriz Zayas, Ph.D.
Universidad Metropolitana, San Juan, PR

“My long-range career objective is to continue directing the ChEMTox laboratory at my institution, where I can develop my line of research and mentor undergraduate and graduate students on toxicology and drug development.”

Abstract #4474 Cellular effects of fluorescent quinolinium drugs on normal lymphoblast and A431 carcinoma cells.
Poster Session: Tuesday, April 5, 2011, 1:00 pm - 5:00 pm, Orange County Convention Center, Exhibit Hall A4C

Abstract #1342  Effects of the plasticizer metabolite 2 ethyl-1-hexanol on human lymphoblast cells.
Poster Session: Monday, April 4, 8:00 am - 12:00 noon, Orange County Convention Center, Exhibit Hall A4C

 

Back to top